BetterLife Pharma Expands Board to Six Members With Doug Drysdale as Executive Chairman
BetterLife Pharma named Doug Drysdale as Executive Chairman and Director, effective May 13, 2026, increasing its board to six members. Drysdale brings over two decades of pharmaceutical leadership experience and will drive corporate strategy and governance enhancements.
1. Appointment of Executive Chairman
BetterLife Pharma appointed Doug Drysdale as Executive Chairman and Director, effective May 13, 2026. Drysdale joins the board, increasing its membership to six, and will lead governance initiatives and corporate strategy, leveraging over two decades of leadership in the pharmaceutical sector.
Related News
BLTE
Belite Bio Begins FDA NDA Rolling Submission, Q1 Loss Widens on $15.7M R&D
BLTE•
SLAB
Silicon Labs SoC Powers 500,000 Wi-SUN Module Shipment for India Grid
SLAB•
MSFT
Microsoft’s AI Spending Drives 50% of Nvidia’s $38 B Data Center Revenue
MSFT•
UPS
UPS MD-11 Crash After Engine Mount Inspections Extended to 29,260 Cycles
UPS•
SHEL
Shell ex-dividend cuts FTSE 100 by 6.84 points
SHEL•
Sources
F